Synthesis and Characterization of a Novel gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy

导出原文传递

翻译打印收藏纠错

作者： Poe, Michael M. ^[1] ; Methuku, Kashi Reddy ^[2] ; Li, Guanguan ^[1] ; Verma, Ashwini ^[1] ; Teske, Kelly A. ^[1] ; Stafford, Douglas C. ^[3] ; Arnold, Leggy A. ^[3] ; Cramer, Jeffrey W. ^[4] ; Jones, Timothy M. ^[3] ; Cerne, Rok ^[3] ; Krambis, Michael J. ^[3] ; Witkin, Jeffrey M. ^[3] ; Jambrina, Enrique ^[1] ; Rehman, Sabah ^[4] ; Ernst, Margot ^[3] ; Cook, James M. ^[3] ; Schkeryantz, Jeffrey M. ^[1]

作者单位： Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 42685 USA ^[1] Eli Lilly & Co, Lilly Res Labs, Alcobendas 28108, Spain ^[2] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA ^[3] Med Univ Vienna, Dept Mol Neurosci, A-1090 Vienna, Austria ^[4]

发布时间 2017-04-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Medicinal Chemistry

2016年59卷23期

10800-10806页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Synthesis and Characterization of a Novel gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Synthesis and Characterization of a Novel gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

检索历史清除